Trials / Completed
CompletedNCT05944484
Effect of Visceral vs Total Body Fat Reduction in Obese Female With Stress Urinary Incontinence
Effect of Visceral vs Total Body Fat Reduction in Obese Female With Stress Urinary Incontinence by EMG and Iciq Questionnaire
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Dina Mohamed Tarek Mansour El-kasrawy · Academic / Other
- Sex
- Female
- Age
- 35 Years – 48 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the visceral fat reduction versus total body fat reduction on stress urinary incontinence in obese females.
Detailed description
compare the effect of visceral fat reduction versus total body fat reduction on stress urinary incontinence in obese females. control group: consist of 20 obese women. They will receive Kegel exercises only 3 session/ week for 12 weeks. Diet group: consist of 20 obese women. They will receive low caloric diet and Kegel exercises 3 session/week for 12 weeks. Ultrasound cavitation group: consist of 20 obese women. They will receive Kegel exercises 3 session/week and ultrasound cavitation two sessions per week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | low caloric diet, ultrasound cavitation,Kegel exercises | * low caloric diet (800-1200) calories/day,). According to each patient, diet contained (carbohydrate protein, fats, minerals, vitamins). 50 to 55% of total calories are carbohydrates, 10 to 15% of total calories protein. Fat limited to less than about 28% of daily total calories .Women took 1200 calories in the first month, 1000 calories in the second month, and 800 calories in the third month. Every week, each woman allowed to change the types of food to avoid boarding. * ultrasound cavitation emits low-frequency ultrasound 40 khz for 30 minutes on abdomen twice/ week with 3 days apart for 12 weeks. kegel exercise: Each woman in the study took the same Kegel exercise program performed the Kegel exercise for 12 weeks (3 sessions per week) |
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2023-05-05
- Completion
- 2023-06-05
- First posted
- 2023-07-13
- Last updated
- 2023-07-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05944484. Inclusion in this directory is not an endorsement.